| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-5728(02)00272-2 |
| P698 | PubMed publication ID | 12458045 |
| P2093 | author name string | Joseph Rogers | |
| Kyle Mueller | |||
| Gregory J Cole | |||
| Mauricio Ramirez | |||
| Ron Strohmeyer | |||
| P2860 | cites work | Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain | Q22253180 |
| RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease | Q24314906 | ||
| Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
| Inflammation and Alzheimer's disease | Q28138617 | ||
| Complement factor H and related proteins: an expanding family of complement-regulatory proteins? | Q28252778 | ||
| An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain | Q28258921 | ||
| Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma | Q28645584 | ||
| Identification of human complement Factor H as a ligand for L-selectin | Q29543695 | ||
| Function and activation of NF-kappa B in the immune system | Q29547790 | ||
| Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders | Q33376704 | ||
| The role of integrins in immune-mediated diseases of the nervous system | Q33544245 | ||
| FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function | Q33594106 | ||
| The factor H protein family | Q33688567 | ||
| Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice | Q34076162 | ||
| NF-kappa B: a crucial transcription factor for glial and neuronal cell function | Q34428983 | ||
| Biochemical and functional characterization of the factor-H-related protein 4 (FHR-4). | Q34457545 | ||
| Complement proteins and complement inhibitors in Alzheimer's disease | Q35556129 | ||
| Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. | Q35787956 | ||
| Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease | Q36771851 | ||
| Proteoglycans as modulators of growth factor activities | Q37656847 | ||
| Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes | Q37671601 | ||
| Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review | Q37934582 | ||
| Transcriptional regulation of the interleukin-1beta promoter via fibrinogen engagement of the CD18 integrin receptor | Q38325141 | ||
| Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses | Q38715604 | ||
| The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity | Q39063137 | ||
| Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction | Q39114018 | ||
| Complement biosynthesis in the central nervous system | Q40406085 | ||
| Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. | Q40893812 | ||
| Integrins: possible functions in the adult CNS. | Q41120781 | ||
| Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils | Q41173971 | ||
| The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation | Q41280940 | ||
| Alzheimer's disease and heparan sulfate proteoglycan. | Q41715940 | ||
| Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease | Q41751577 | ||
| Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution | Q42153291 | ||
| Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin | Q42472113 | ||
| Identification of human complement factor H as a chemotactic protein for monocytes. | Q42987610 | ||
| Evidence for an active hydrophobic form of factor H that is able to induce secretion of interleukin 1-β or by human monocytes | Q46237179 | ||
| A new biological activity of the complement factor H: identification of the precursor of the major macrophage-chemotactic factor in delayed hypersensitivity reaction sites of guinea pigs | Q46729890 | ||
| Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease | Q46852742 | ||
| Complement regulation | Q47686748 | ||
| Mechanisms of cell death in Alzheimer disease--immunopathology. | Q48330745 | ||
| The importance of inflammatory mechanisms in Alzheimer disease | Q48380991 | ||
| Integrin Mac-1 and beta-amyloid in microglial release of nitric oxide. | Q48593698 | ||
| Brain microglia constitutively express beta-2 integrins. | Q48874195 | ||
| Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. | Q48933977 | ||
| Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. | Q53237812 | ||
| Crucial role of heparan sulfate proteoglycan (agrin) in beta-amyloid formation in Alzheimer's disease. | Q53238449 | ||
| Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. | Q53341475 | ||
| Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide | Q57897218 | ||
| Heparin specifically inhibits binding of apolipoprotein E to amyloid β-peptide | Q57996004 | ||
| Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix | Q57996135 | ||
| Proteoglycans and the extracellular matrix in amyloidosis | Q58283024 | ||
| Agrin and microvascular damage in Alzheimer’s disease | Q60145604 | ||
| Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes | Q67662039 | ||
| Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra | Q68173181 | ||
| pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans | Q72621597 | ||
| Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H | Q72733127 | ||
| Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils | Q73684083 | ||
| CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin | Q74087960 | ||
| Localization of human serum amyloid P component and heparan sulfate proteoglycan in in vitro-formed Abeta fibrils | Q74130148 | ||
| Molecular and cellular mediators of Alzheimer's disease inflammation | Q74736408 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 135-146 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. | |
| P478 | volume | 131 |
| Q42026180 | Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline |
| Q33920123 | Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration |
| Q46830145 | Association of complement factor H Y402H gene polymorphism with Alzheimer's disease |
| Q37505868 | CCAAT-enhancer binding protein-β expression and elevation in Alzheimer's disease and microglial cell cultures |
| Q36565635 | CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease |
| Q41897818 | CSF Biomarkers for Alzheimer's Disease Diagnosis |
| Q36592268 | CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease |
| Q30665205 | Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia |
| Q53290404 | Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease. |
| Q37872442 | Complement in the brain. |
| Q30665192 | Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides |
| Q38362621 | Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation |
| Q37769045 | Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis |
| Q42103651 | Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH. |
| Q38223669 | Factor h: a complement regulator in health and disease, and a mediator of cellular interactions. |
| Q48158817 | Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation |
| Q41705490 | Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. |
| Q35677347 | Immune aging, dysmetabolism, and inflammation in neurological diseases |
| Q38120744 | Innate immunity and neuroinflammation |
| Q34630522 | Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment |
| Q38195641 | Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis |
| Q42322507 | Microglia, Alzheimer's disease, and complement |
| Q34521923 | Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity |
| Q37678533 | Microglial dysfunction in brain aging and Alzheimer's disease |
| Q28259238 | Neuroinflammation in Alzheimer's disease |
| Q28070156 | Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? |
| Q37068847 | Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease |
| Q60693530 | Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer’s Disease |
| Q46155330 | Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease |
| Q26750630 | Redox Imbalance and Viral Infections in Neurodegenerative Diseases |
| Q33787737 | Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). |
| Q43162540 | Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration. |
| Q58738012 | Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces |
| Q24796236 | Using animal models to determine the significance of complement activation in Alzheimer's disease |
| Q34976109 | Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration. |
| Q38887260 | c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes |
Search more.